Association study between polymorphims in GAS6-TAM genes and carotid atherosclerosis

Journal: Thrombosis and Haemostasis
ISSN: 0340-6245

Theme Issue: Highlights from EMVBM 2009

Issue: 2010: 104/3 (Sep) pp. 421–653
Pages: 592-598

Association study between polymorphims in GAS6-TAM genes and carotid atherosclerosis

Online Supplementary Material

B. Hurtado (1, 2), N. Abasolo (1), X. Muñoz (1), N. García (1), Y. Benavente (3, 4), F. Rubio (5), P. García de Frutos (2), J. Krupinski (6, 7, 8), N. Sala (1)

(1) Translational Research Laboratory, Catalan Institute of Oncology-IDIBELL, L’Hospitalet de Llobregat, Spain; (2) Department of Cell Death and Proliferation, Institute for Biomedical Research of Barcelona (IIBB-CSIC-IDIBAPS), Barcelona, Spain; (3) Unit of Infections and Cancer, Cancer Epidemiology ResearchProgramme, Catalan Institute of Oncology-IDIBELL, L’Hospitalet de Llobregat, Spain; (4) CIBERESP, L’Hospitalet de Llobregat, Spain; (5) Neurology Service, Hospital Universitari de Bellvitge, L’Hospitalet de Llobregat, Spain; (6) School of Biology, Chemistry and Health Science, and Faculty of Medical and Human Sciences, University of Manchester, Manchester, UK; (7) Department of Neurology, Stroke Unit, Hospital Universitari Mutua de Terrassa, Terrassa, Spain; (8) Fundacio IDIBELL, Barcelona, Spain


Atherosclerosis, polymorphisms, GAS6, TAM receptors, genetic susceptibility


Carotid atherosclerosis (CA) is one of the most common causes of stroke, and recent studies suggest that pathways initiated by the interaction of the plasma vitamin K-dependent protein GAS6 with the tyrosine kinase receptors TYRO3, AXL and MERTK (TAM) may have a relevant role in atherogenesis. Furthermore, our previous studies indicated an association between GAS6 and stroke. The aim of this study was to analyse the genetic association between SNPs and haplotypes in GAS6-TAM genes and CA. We performed a case-control study with 233 CA patients confirmed by nuclear magnetic resonance angiography and 202 patients who suffered from cardioembolic (non atherogenic) stroke. For all included subjects information on established risk factors was available. Genotyping of 16 selected tagSNPs was performed by real-time PCR, using either FRET or TaqMan probes. Adjusted logistic regression (LR) analyses indicated that rs2289743 in TYRO3 and rs869016 in MERTK were associated to CA, decreasing its risk (OR [95%CI]=0.39 [0.16–0.94] and OR [95%CI]=0.31 [0.14–0.69], respectively). Linkage disequilibrium results were consistent with the haplotype blocks described in HapMap and adjusted LR analyses revealed that the haplotype ACAA in MERTK , containing the minor allele of the associated SNP, was also associated to CA. No association was observed with GAS6 and AXL variants, which suggests that CA is not the mechanism underlying the reported association between GAS6 and stroke. The association between TYRO3 and MERTK variants and carotid atherosclerosis found in this study reinforces a physiological role of the GAS6-TAM pathway in atherogenesis.

You may also be interested in...

Xavier Muñoz1*, Víctor Obach 2, Begoña Hurtado1*, Pablo García de Frutos 3, Ángel Chamorro 2, Núria Sala1*

Thromb Haemost 2007 98 2: 406-412


Online Supplementary Material

S. Clauser (1, 2, 3), O. Meilhac (4, 5, 6), I. Bieche (7, 8), P. Raynal (9), P. Bruneval (8, 10, 11), J.-B. Michel (4, 5, 6), D. Borgel (1, 2)

Thromb Haemost 2012 107 1: 140-149


Andreas E. May, Tobias Geisler, Meinrad Gawaz

Thromb Haemost 2008 99 3: 487-493